Skip to main content
Screener/Healthcare/Biotechnology

AARD Aardvark Therapeutics, Inc. Common Stock

NASDAQ
$5.30-0.43 (-7.50%)
$3.35
$17.94
$5.15
$5.99
EPS (TTM)$-3.21
P/E Ratio-2.12
Dividend Yield
Market Cap$138.3M
Volume233K
Prev Close$5.73
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$21.6M$-0.99
Q4 '25$0-$17.6M$-0.81
Q3 '25$0-$16.3M$-0.75
Q2 '25$0-$14.4M$-0.66
Q1 '25$0-$9.3M$-0.43
Q4 '24$0-$8.8M$-0.40
Q3 '24$0-$4.2M$-0.20
Q2 '24$0-$5.4M$-0.25
Get Your Daily Market Recap